The global gene therapy market is likely to grow at an impressive CAGR over the forecast period, owing to recent technological advancements in gene replacement procedures. According to a report by Fortune Business Insights, titled ‘Gene Therapy: Global Market Analysis, Insights and Forecast, 2018 – 2025’ the market is likely to expand at a high rate due to increasing adoption of gene therapy in several countries across the world.
For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/gene-therapy-market-100243
Recently, there has been a growing emphasis on development of new gene replacement therapies. Encouraged by advancements in gene therapy and a high demand from end users, many companies are investing more in the research and development (R&D) of these products. According to Fortune Business Insights, in the coming years the market is likely to gain from the rising demand for gene therapy for haemophilia and other diseases.
some of the key players in the global Gene Therapy Market:
- Pfizer Inc.
- Novartis AG
- Bayer AG
- Sanofi
- GlaxoSmithKline plc.
- Amgen Inc.
- Boehringer Ingelheim International GmbH
- uniQure N.V.
- bluebird bio, Inc.
- Celgene Corporation
The exceptional benefits of gene therapy include replacement of a defective gene altogether. In initial years, research analysts were more focused on repairing the defective genes, but with the option of replacing the gene altogether, more end users are opting for gene therapy process. This factor has had a positive impact on the global gene therapy market and the increasing adoption is likely to drive the market in the forecast period.
Introduction of New Tools in Gene Therapy to Drive the Market
Regenerative medicine is an emerging area of research and development, with research analysts expressing their intent of emphasizing on developments in gene therapy. As gene therapies involve infusion of new genes into cells for regeneration of tissues, tools used for these therapies need to be precise and of high calibre. Thus, the focus of existing companies is gradually shifting towards the development of novel and more advanced tools. This offers growth opportunities for existing as well as new players in the market.
